JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Fragment 176-191 represents a modified segment of the growth hormone molecule, specifically encompassing amino acids 176-191 of the human growth hormone sequence. This peptide fragment has garnered significant attention in metabolic research laboratories for its unique properties in lipid metabolism studies. Research institutions utilize this compound extensively in cellular assays investigating adipocyte function, lipolytic pathways, and energy expenditure mechanisms in controlled laboratory environments.
Establish optimal laboratory conditions by ensuring all work surfaces undergo thorough decontamination using appropriate disinfectants. Verify that the laminar flow hood operates correctly with adequate airflow patterns. Allow the lyophilised Fragment 176-191 vial to equilibrate to room temperature for approximately 15-20 minutes before commencing reconstitution procedures. This temperature equilibration prevents thermal shock and ensures consistent solubility characteristics.
Inspect the lyophilised powder for uniform appearance and absence of discoloration or clumping. The powder should exhibit a white to off-white appearance with fine, uniform texture. Document any observations regarding the physical characteristics of the starting material in laboratory records.
Step 1: Position the Fragment 176-191 vial securely within the laminar flow hood and remove the protective cap. Clean the rubber stopper thoroughly using alcohol prep pads, allowing complete evaporation of residual alcohol before proceeding.
Step 2: Using aseptic technique, draw the predetermined volume of bacteriostatic water into a sterile syringe. Calculate the required volume based on desired final concentration using the formula: Volume (mL) = Mass (mg) ÷ Desired Concentration (mg/mL).
Step 3: Insert the needle through the rubber stopper at a slight angle, ensuring the bevel faces downward. Direct the solvent flow toward the vial wall rather than directly onto the lyophilised cake to minimize foaming and preserve peptide integrity.
Step 4: Inject the solvent slowly and steadily, maintaining gentle pressure to create a smooth flow. Observe the reconstitution process, noting the dissolution pattern and ensuring no excessive agitation occurs during solvent addition.
Step 5: After complete solvent addition, gently swirl the vial in circular motions to facilitate dissolution. Avoid vigorous shaking or vortexing, which may cause protein denaturation or excessive foam formation.
Step 6: Allow the vial to stand undisturbed for 2-3 minutes, permitting complete hydration of the peptide. If necessary, apply gentle finger-tapping to the vial sides to encourage dissolution of any remaining particles.
Step 7: Visually inspect the reconstituted solution for complete dissolution and clarity. The final solution should appear clear and colorless without visible particulates or precipitates.
Store the reconstituted Fragment 176-191 solution under refrigerated conditions at 2-8°C for short-term stability up to 4 weeks. For extended storage periods, aliquot the solution into smaller volumes using sterile amber vials to minimize freeze-thaw cycles. Long-term storage at -20°C maintains peptide stability for up to 6 months when properly sealed and protected from light exposure.
Label all storage containers with reconstitution date, concentration, and storage temperature requirements. Implement a first-in, first-out inventory system to ensure optimal utilization of research materials within their stability timeframes.
Element SARMs Fragment 176-191 demonstrates optimal performance in cell culture assays when diluted to working concentrations immediately before experimental use. Research laboratories commonly employ this peptide in studies examining adipose tissue metabolism, cellular energy expenditure, and lipolytic enzyme activity. The reconstituted material maintains consistent biological activity when handled according to these established protocols, ensuring reproducible experimental outcomes across multiple research sessions.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.